Biosion Inc. 13D and 13G filings for Aclaris Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-25 11:02 am Purchase | 2024-11-18 | 13G | Aclaris Therapeutics, Inc. ACRS | Biosion Inc. | 11,281,985 9.500% | 11,281,985 (New Position) | Filing |